Titlebook: Volume Replacement; Jean-Francois Baron,Johannes Treib Conference proceedings 1998 Springer-Verlag Berlin Heidelberg 1998 Blutersatzstoffe

正式通知

Use of Plasma Substitutes During Cardiac Surgery: Focus on Priming Solutions,omeostasis. With the initiation of CPB, an extra void is added to the intravascular space by connecting arterial and venous vascular trees to an ex vivo machinery including plastic tubing, filters, pumps, and an artificial lung. This expansion requires an appropriate solution to fill the extracorpor

GEON

Colloid-Induced Renal Complications,hearing loss, to improve microcirculatory perfusion and collateral flow. Since these patients usually have generalized atherosclerosis, often with some degree of preexisting latent renal disease, it is not surprising that the colloids, albumin, dextran, and HES are occasionally associated with the d

向外才掩飾

New Therapeutic Concepts Using Artificial Oxygen Carriers,e to allogeneic blood transfusions or to improve tissue oxygenation and the function of organs with marginal O. supply. The aim of the present article is to describe the artificial O. carriers that have currently been evaluated, to summarize their efficiency and to discuss potential side effects.

PHAG

Conference proceedings 1998ve shown that bleeding disorders, anaphylactic reactions and storage in the body depend decisively on the nature of the administered plasma substitute. Through interdisciplinary cooperation the "First European Volume Replacement Conference" has established indications for the use of individual plasm

詞根詞綴法

Use of Gelatins as Volume Expanders in Shock and Trauma, volume replacement theory in shock has to be considered in this context. The relationship between the delivery of oxygen (DO.) and oxygen consumption (VO.) is known as the oxygen transport (O.T) system. This is primarily considered in quantitative terms; normal values are summarised in Fig. 2.1.

女歌星

cavity

延期

培養(yǎng)

展覽

substitute. Through interdisciplinary cooperation the "First European Volume Replacement Conference" has established indications for the use of individual plasma substitutes to improve the efficacy and therapeutic safety of volume replacement therapy.978-3-540-64187-2978-3-642-72170-0